6-[(S)-1-(tetrahydrofuran-2-yl)methoxy]-isochroman-1-one | 947150-02-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡喃
• 英文名称: 6-[(S)-1-(tetrahydrofuran-2-yl)methoxy]-isochroman-1-one
• 英文别名: 6-[(S)-1-(Tetrahydrofuran-2-yl)methoxy]isochroman-1-one；6-[[(2S)-oxolan-2-yl]methoxy]-3,4-dihydroisochromen-1-one
• CAS: 947150-02-9
• 化学式: C₁₄H₁₆O₄
• 分子量: 248.279
• InChiKey: JPJIDQZERFVBEN-LBPRGKRZSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  44.8
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  6-[(S)-1-(tetrahydrofuran-2-yl)methoxy]-isochroman-1-one 在 氯化亚砜 作用下， 生成 2-(2-chloroethyl)-4-[(S)-1-(tetrahydrofuran-2-yl)methoxy]benzoyl chloride
  参考文献：
  名称：

  NOVEL SUBSTITUTED INDANES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF AS DRUGS

  摘要：

  该发明涉及取代吲哚烷及其衍生物，以及其生理上可接受的盐和生理功能衍生物，以及其生产，包含至少一种根据该发明的取代吲哚烷或其衍生物的药物，以及将根据该发明的取代吲哚烷及其衍生物用作MCH拮抗剂。

  公开号：

  US20120022039A1
• 作为产物：
  描述：

  (S)-(tetrahydrofuran-2-yl)methyl methanesulfonate 、 6-羟基-3,4-二氢-1H-异苯并吡喃-1-酮 在 C14H28FN3O3 作用下， 生成 6-[(S)-1-(tetrahydrofuran-2-yl)methoxy]-isochroman-1-one
  参考文献：
  名称：

  Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments

  摘要：

  本发明涉及含氮杂环取代的芳基二氢异喹啉酮及其衍生物，其生理耐受盐和生理功能衍生物，其制备方法，至少包括本发明中的一种含氮杂环取代的芳基二氢异喹啉酮或其衍生物的药物，以及将本发明中的含氮杂环取代的芳基二氢异喹啉酮及其衍生物用作MCH拮抗剂。

  公开号：

  US08822495B2

文献信息

• NOVEL SUBSTITUTED TETRAHYDRONAPHTHALENES, PROCESS FOR THE PREPARATION THEREOF AND THE USE THEREOF AS MEDICAMENTS
  申请人：SCHWINK Lothar

  公开号：US20100249097A1

  公开（公告）日：2010-09-30

  The invention relates to substituted tetrahydronaphthalenes and derivatives thereof, and also to the physiologically compatible salts and physiologically functional derivatives thereof, to preparation thereof, to medicaments comprising at least one inventive substituted tetrahydronaphthalene or derivative thereof, and to the use of the inventive substituted tetrahydronaphthalenes and derivatives thereof as medicaments.

  该发明涉及替代四氢萘及其衍生物，以及与之相关的生理相容盐和生理功能衍生物，其制备方法，包含至少一种创新替代四氢萘或其衍生物的药物，以及将创新替代四氢萘及其衍生物用作药物的用途。
• NOVEL AZACYCLYL-SUBSTITUTED ARYLDIHYDROISOQUINOLINONES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
  申请人：SCHWINK Lothar

  公开号：US20090264403A1

  公开（公告）日：2009-10-22

  The invention relates to azacyclyl-substituted aryldihydroisoquinolinones and their derivatives, and their physiologically tolerated salts and physiologically functional derivatives, their preparation, medicaments comprising at least one azacyclyl-substituted aryldihydroisoquinolinone of the invention or its derivative, and the use of the azacyclyl-substituted aryidihydroisoquinolinones of the invention and their derivatives as MCH antagonists.

  本发明涉及含氮杂环取代的芳基二氢异喹啉酮及其衍生物、其生理上可耐受的盐和生理功能衍生物、其制备方法、包含本发明中至少一种含氮杂环取代的芳基二氢异喹啉酮或其衍生物的药物以及将本发明中的含氮杂环取代的芳基二氢异喹啉酮及其衍生物用作MCH拮抗剂。
• NOVEL AMINOALCOHOL-SUBSTITUTED ARYLDIHYDROISOQUINOLINONES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
  申请人：SCHWINK Lothar

  公开号：US20090082391A1

  公开（公告）日：2009-03-26

  The invention relates to aminoalcohol-substituted aryldihydroisoquinolinones and their derivatives, and their physiologically tolerated salts and physiologically functional derivatives, their preparation, medicaments comprising at least one aminoalcohol-substituted aryldihydroisoquinolinone of the invention or its derivative, and the use of the aminoalcohol-substituted aryldihydroisoquinolinones of the invention and their derivatives as MCH antagonists.

  本发明涉及氨基醇取代的芳基二氢异喹啉酮及其衍生物，以及其生理耐受盐和生理功能衍生物、其制备方法、至少包含本发明中的一种氨基醇取代的芳基二氢异喹啉酮或其衍生物的药物，以及将本发明中的氨基醇取代的芳基二氢异喹啉酮及其衍生物用作MCH拮抗剂的用途。
• Aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
  申请人：Schwink Lothar

  公开号：US08501771B2

  公开（公告）日：2013-08-06

  The invention relates to aminoalcohol-substituted aryldihydroisoquinolinones and their derivatives, and their physiologically tolerated salts and physiologically functional derivatives, their preparation, medicaments comprising at least one aminoalcohol-substituted aryldihydroisoquinolinone of the invention or its derivative, and the use of the aminoalcohol-substituted aryldihydroisoquinolinones of the invention and their derivatives as MCH antagonists.

  本发明涉及氨基醇取代的芳基二氢异喹啉酮及其衍生物，以及其生理上耐受的盐和生理学功能衍生物，其制备，包含本发明中至少一种氨基醇取代的芳基二氢异喹啉酮或其衍生物的药物，以及将本发明中的氨基醇取代的芳基二氢异喹啉酮及其衍生物用作MCH拮抗剂的用途。
• Substituted tetrahydronaphthalenes, process for the preparation thereof and the use thereof as medicaments
  申请人：Schwink Lothar

  公开号：US08609731B2

  公开（公告）日：2013-12-17

  The invention relates to substituted tetrahydronaphthalenes and derivatives thereof, and also to the physiologically compatible salts and physiologically functional derivatives thereof, to preparation thereof, to medicaments comprising at least one inventive substituted tetrahydronaphthalene or derivative thereof, and to the use of the inventive substituted tetrahydronaphthalenes and derivatives thereof as medicaments.

  本发明涉及取代四氢萘及其衍生物，以及其生理相容盐和生理功能衍生物，其制备方法，包含至少一种本发明的取代四氢萘或其衍生物的药物，以及将本发明的取代四氢萘及其衍生物用作药物的用途。